Legionnaires’ disease is a rare condition, and incidence is hard to estimate because diagnosis requires a suspicion of ...

Discover Insmed's innovative therapies targeting rare diseases, with approvals like Brinsupri boosting potential.

Patients with IBD have a higher risk for interstitial lung disease than the general population, with the risk being more ...

A new study offers encouraging news for older adults with chronic respiratory conditions who may struggle to access traditional gym-based rehabilitation programs. Researchers found that pulmonary ...

Liquidia Corporation LQDA reported a loss for the second quarter on Tuesday. The company posted a second-quarter loss of 49 ...

Consistently tracking KL-6 levels may help predict acute exacerbations in IPF and other types of fibrotic ILDs, a study ...

Large cohort study finds interstitial lung disease independently increases lung cancer risk across all major subtypes, even ...

Net loss for the three months ended June 30, 2025, was $41.6 million or $0.49 per basic and diluted share, compared to a net loss of $28.7 million, or $0.38 per basic and diluted share, for the three ...

Continued approval for this indication is contingent upon verification and description of clinical benefit in a confirmatory trial.

Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic ...

After positive trial results for TX45, Tectonic Therapeutic is planning a Phase 2 study to test its effects on blood flow in ...